Mon, Sep 22, 2014, 6:46 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Merrimack Pharmaceuticals, Inc. (MACK) Message Board

  • wanna_million wanna_million Feb 14, 2013 2:00 PM Flag

    Credit Suisse increased position 2% or 100,535...filing today

    9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    5,097,450

    10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)

    o

    11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    5.41%

    12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)

    BK , HC


    FOOTNOTES





    --------------------------------------------------------------------------------



    Item 1.

    (a) Name of Issuer

    Merrimack Pharmaceuticals Inc.

    (b) Address of Issuer’s Principal Executive Offices

    82 Devonshire Street
    Boston, MA 02109

    Item 2.

    (a) Name of Person Filing

    Credit Suisse AG/
    See Schedule 99.1

 
MACK
7.17-0.12(-1.65%)Sep 22 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.